Vaxart, Inc. Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price
Vaxart, Inc. (VXRT) had Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price of $4.28 per share as of 2017-06-30, per its 10-K filed 2017-09-01.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 · last filed 2017-09-01
- 2017-06-30: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $4.28.
- 2017-03-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $5.27.
- 2016-06-30: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $6.22.
- 2015-09-30: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $9.61.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2017-06-30 | $4.28 10-K · filed 2017-09-01 |
| 2017-03-31 | $5.27 10-Q · filed 2017-05-08 |
| 2016-06-30 | $6.22 10-K · filed 2016-09-13 |
| 2015-09-30 | $9.61 10-Q · filed 2015-11-06 |
| 2015-06-30 | $10.16 10-K · filed 2015-09-11 |
| 2015-03-31 | $12.74 10-Q · filed 2015-05-08 |
| 2014-12-31 | $12.92 10-Q · filed 2015-02-06 |
| 2014-09-30 | $19.28 10-Q · filed 2014-11-07 |
| 2014-06-30 | $19.51 10-K · filed 2014-09-30 |
| 2014-03-31 | $23.09 10-Q · filed 2014-05-12 |
| 2013-12-31 | $23.75 10-Q · filed 2014-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |